- Home
- SCWO vs PYPD Comparison
SCWO vs PYPD Comparison
Compare SCWO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- PYPD
- Stock Information
- Founded
- SCWO 2021
- PYPD 2008
- Country
- SCWO United States
- PYPD Israel
- Employees
- SCWO N/A
- PYPD N/A
- Industry
- SCWO Environmental Services
- PYPD Medical/Dental Instruments
- Sector
- SCWO Utilities
- PYPD Health Care
- Exchange
- SCWO Nasdaq
- PYPD Nasdaq
- Market Cap
- SCWO 35.5M
- PYPD 34.8M
- IPO Year
- SCWO N/A
- PYPD 2020
- Fundamental
- Price
- SCWO $0.24
- PYPD $3.50
- Analyst Decision
- SCWO
- PYPD Strong Buy
- Analyst Count
- SCWO 0
- PYPD 5
- Target Price
- SCWO N/A
- PYPD $12.00
- AVG Volume (30 Days)
- SCWO 1.2M
- PYPD 65.8K
- Earning Date
- SCWO 08-12-2025
- PYPD 08-13-2025
- Dividend Yield
- SCWO N/A
- PYPD N/A
- EPS Growth
- SCWO N/A
- PYPD N/A
- EPS
- SCWO N/A
- PYPD N/A
- Revenue
- SCWO $1,231,413.00
- PYPD N/A
- Revenue This Year
- SCWO $5,945.19
- PYPD N/A
- Revenue Next Year
- SCWO $106.82
- PYPD N/A
- P/E Ratio
- SCWO N/A
- PYPD N/A
- Revenue Growth
- SCWO 403.17
- PYPD N/A
- 52 Week Low
- SCWO $0.16
- PYPD $2.30
- 52 Week High
- SCWO $1.99
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- SCWO 45.94
- PYPD 53.00
- Support Level
- SCWO $0.22
- PYPD $3.45
- Resistance Level
- SCWO $0.27
- PYPD $3.57
- Average True Range (ATR)
- SCWO 0.03
- PYPD 0.22
- MACD
- SCWO 0.00
- PYPD 0.01
- Stochastic Oscillator
- SCWO 68.18
- PYPD 81.13
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.